Evidence map›Paper›PMID 33362267›Full record

ArticlePloS one2020

Novel CRISPR-based sequence specific enrichment methods for target loci and single base mutations.

Jennifer L Steele, Richard C Stevens, Oscar A Cabrera, Gary J Bassill, Sabrina M Cramer, Felipe Guzman, Anthony P Shuber

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jennifer L SteeleGenetics Research LLC, Waltham, Massachusetts, United States of America.ORCID 0000-0001-7559-0189
Richard C StevensGenetics Research LLC, Waltham, Massachusetts, United States of America.ORCID 0000-0003-4278-5654
Oscar A CabreraGenetics Research LLC, Waltham, Massachusetts, United States of America.
Gary J BassillGenetics Research LLC, Waltham, Massachusetts, United States of America.
Sabrina M CramerGenetics Research LLC, Waltham, Massachusetts, United States of America.
Felipe GuzmanGenetics Research LLC, Waltham, Massachusetts, United States of America.
Anthony P ShuberGenetics Research LLC, Waltham, Massachusetts, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The programmable sequence specificity of CRISPR has found uses in gene editing and diagnostics. This manuscript describes an additional application of CRISPR through a family of novel DNA enrichment technologies. CAMP (CRISPR Associated Multiplexed PCR) and cCAMP (chimeric CRISPR Associated Multiplexed PCR) utilize the sequence specificity of the Cas9/sgRNA complex to target loci for the ligation of a universal adapter that is used for subsequent amplification. cTRACE (chimeric Targeting Rare Alleles with CRISPR-based Enrichment) also applies this method to use Cas9/sgRNA to target loci for the addition of universal adapters, however it has an additional selection for specific mutations through the use of an allele-specific primer. These three methods can produce multiplex PCR that significantly reduces the optimization required for every target. The methods are also not specific to any downstream analytical platform. We additionally will present a mutation specific enrichment technology that is non-amplification based and leaves the DNA in its native state: TRACE (Targeting Rare Alleles with CRISPR-based Enrichment). TRACE utilizes the Cas9/sgRNA complex to sterically protect the ends of targeted sequences from exonuclease activity which digests both the normal variant as well as any off-target sequences.

Indexed as

Base SequenceClustered Regularly Interspaced Short Palindromic RepeatsGene EditingGenetic LociGenome, HumanHumansPolymorphism, Single Nucleotide

Identifiers

PMID33362267
PMCPMC7757808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.